Earlier studies have suggested that halothane may relax smooth muscle in part by opening adenosine triphosphate-sensitive potassium (K ATP ) channels. We tested this hypothesis in vitro by examining the interaction of halothane with glibenclamide, a K ATP channel blocker, and YM934, a K ATP channel opener, in strips of canine tracheal smooth muscles mounted in an organ bath system. To examine the specificity of any effects of halothane on the K ATP channel, we assessed the interaction of halothane with tetraethylammonium (TEA), an antagonist of the large-conductance, calcium-activated potassium channel. Experiments were conducted with drugs added before exposure to increasing concentrations of acetylcholine (ACh), and with drugs added after stable increases in force produced by ACh were achieved (ACh precontraction 
Summary
Earlier studies have suggested that halothane may relax smooth muscle in part by opening adenosine triphosphate-sensitive potassium (K ATP ) channels. We tested this hypothesis in vitro by examining the interaction of halothane with glibenclamide, a K ATP channel blocker, and YM934, a K ATP channel opener, in strips of canine tracheal smooth muscles mounted in an organ bath system. To examine the specificity of any effects of halothane on the K ATP channel, we assessed the interaction of halothane with tetraethylammonium (TEA), an antagonist of the large-conductance, calcium-activated potassium channel. Experiments were conducted with drugs added before exposure to increasing concentrations of acetylcholine (ACh), and with drugs added after stable increases in force produced by ACh were achieved (ACh precontraction). Exposure to halothane 0.62 mmol litre Halothane is a potent bronchodilator, relaxing airway smooth muscle both by depressing neural pathways innervating the muscle and by a direct effect on the smooth muscle cell [1, 2] . One proposed mechanism for this effect is a decrease in intracellular calcium concentration [3, 4] , produced in part by depression of calcium influx via voltage-sensitive calcium channels in the sarcolemma. Under voltageclamped conditions, halothane depresses the function of these channels in several types of cells [5] , including vascular smooth muscle [6, 7] . Changes in membrane potential could also affect calcium channel function. Hyperpolarization of the cell membrane has been suggested as a mechanism for anaesthetic action in several cell types [8] , including airway smooth muscle [9] . One mechanism that could produce hyperpolarization would be an increase in conductance of potassium channels [10] . In support of such a mechanism in airway smooth muscle, Mehr and Lindeman [11] found that glibenclamide, an antagonist of adenosine triphosphate (ATP)-sensitive potassium (KATP) channels, abolished the ability of halothane to decrease airway responsiveness to hypocapnia in a canine model of asthma. Evidence for activation of potassium channels has been reported for several other types of cells, including activation of the KATP channel in vascular smooth muscle [12] . However, there is also considerable evidence that halothane depresses the function of several types of potassium channels [6, 7, [13] [14] [15] , although the KATP channel has not been examined specifically.
The purpose of this study was to test the hypothesis that halothane relaxes airway smooth muscle in vitro, in part by activation of KATP channels. We examined the interaction of halothane with glibenclamide and YM934, a KATP channel opener [16] , during stimulation of isolated strips of canine tracheal smooth muscle with acetylcholine (ACh). To determine the specificity of any effects of halothane on the KATP channel, we also examined the interaction of halothane with tetraethylammonium (TEA), an antagonist of the large-conductance, calcium-activated potassium (KCa) channel.
Materials and methods

TISSUE PREPARATION
The trachea was removed from 45 mongrel dogs anaesthetized with pentobarbitone and exsanguinated. The tissue was immersed immediately in a chilled physiological salt solution (PSS) of the following composition (mmol litre NaHCO3 25.7 and glucose 5.6. After removal of the epithelium and connective tissue, rectangular strips of smooth muscle (10-15 mm long and 2 mm wide) were dissected from the middle of the trachea. Each strip was suspended vertically in a 25-ml waterjacketed tissue bath containing PSS at 37 ЊC and bubbled with 94 % oxygen-6 % carbon dioxide, providing a pH of 7.4, Po2 of 73 kPa and PCO2 of 4.8 kPa (Instrumentation Laboratories model 1302). The strips were connected to strain gauges (Grass FT03) for isometric force recording (HewlettPackard 7418A). Indomethacin 10 mol litre 91 was added to all baths.
The strips were washed in PSS for approximately 2 h while being stimulated supramaximally (0.5-ms pulse duration, 25 Hz, 15 V) by electrical field stimulation at 5-min intervals. Muscle length was increased after each contraction until the force of contraction reached a maximum. Each strip was maintained at this optimal length for the duration of the experiment. The contractile response to ACh 100 mol litre
91
, defined as the maximal response, was then determined.
EXPERIMENTAL DESIGNS
Because different mechanisms are involved in the induction compared with the maintenance of force in airway smooth muscle [17] , experiments were conducted both with drugs added before exposure to increasing concentrations of ACh, and with drugs added after stable increases in force produced by ACh were achieved (ACh precontraction).
Interpretation of precontraction experiments is complicated by the fact that the amount of relaxation produced by an antagonist of contraction may depend on both the initial force and the concentration of contractile agonist needed to produce that force (a phenomenon referred to as functional antagonism). In some experiments, prior exposure to a compound with effects on muscle contractility (e.g. halothane) changes the initial force of contraction produced for a given concentration of ACh. In the case of halothane, such an effect is observed even at maximal concentrations of ACh [18] . In these instances, options include maintaining a constant ACh concentration and allowing the initial force to vary, or manipulating ACh concentration to keep the initial force constant between experimental conditions. We chose the latter option, as described below. However, when the ACh concentration needed to produce equal initial forces differed significantly between conditions, we also performed additional experiments, using these different ACh concentrations and allowing initial forces to vary, to determine if functional antagonism was responsible for the observed results.
Four series of experiments were performed, evaluating: (1) the effects of K ; -channel block produced by TEA 1 mmol litre 91 or glibenclamide 10 95 mol litre 91 on the ability of 1.7 % halothane to inhibit force developed in response to cumulative increases in ACh concentrations; (2) the effects of K ; -channel block on the ability of halothane to relax strips precontracted with ACh to approximately 50 % of maximal force; (3) the effect of 1.7 % halothane pretreatment on the ability of YM934, a KATP channel opener, to inhibit force developed in response to cumulative increases in ACh concentrations; and (4) the effects of halothane on the ability of YM934 to relax strips precontracted with ACh to approximately 50 % of maximal force. When appropriate, control experiments were performed with the vehicle used to solubilize glibenclamide (4 10 95 vol % dimethylsulphoxide (DMSO)). In all experiments using ACh precontraction, another strip paired for each experimental condition was used to control for any effects of time on the level of precontraction [1] .
DATA ANALYSIS
Isometric forces were expressed as a percentage of the maximal force (for ACh concentration-response procedures) or as a percentage of the initial force (for ACh precontraction procedures). In strips precontracted with ACh, the contractile responses were adjusted for the effect of time [1] according to the formula:
t C C C C where Ct : the time-adjusted response, C1 : response of time-control muscle (initial measurement), C2 : response of time-control muscle (measured in parallel with the exposed muscle) and Cd : response of the muscle exposed to drug.
Sigmoidal concentration-response curves to ACh or YM934 were analysed using the method of Meddings, Scott and Fick [19] . In this method, force ( F ) at any concentration of drug (C) is given by the equation:
where Fm : maximal (or minimal) force and ED50 : concentration that produces the half-maximal (or minimal) force for that drug. Non-linear regression analysis was used to fit values of Fm and ED50 to data for F and C for each condition studied. This method allows comparison of curves to determine if they are significantly different, and if this overall difference can be attributed to differences in Fm, ED50, or both.
The potency of halothane in relaxing strips precontracted with ACh was quantified by linear regression of the relationship between force and halothane concentration. To test for differences in potency between conditions, slopes were compared by one-way analysis of variance (ANOVA), with post hoc comparisons performed using the StudentNewman-Keuls method.
Data are expressed as mean (SEM). P : 0.05 was considered significant. In all cases n represents the number of pairs of strips analysed for a given experimental condition. For a given condition, each pair of strips was obtained from a different dog.
DRUGS
Halothane (Ayerst Laboratories) was added to the aerating gas mixture via an on-line vaporizer. The concentration of halothane in the gas mixture was monitored continuously by a mass spectrometer (model MGA-1100, Perkin-Elmer). The concen-tration of halothane in the PSS was determined by gas chromatography (model 5880A, HewlettPackard). The drugs used were ACh hydrochloride, indomethacin (Sigma), tetraethylammonium chloride, glibenclamide (Research Biochemicals) and YM934 (Yamanouchi Pharmaceuticals). Drug concentrations are expressed as final bath concentrations of the salts. Halothane produced concentration-dependent relaxation of these precontracted strips ( fig. 3) ; P : 0.01), the ability of halothane to relax strips precontracted with these two concentrations of ACh was studied in separate experiments (in the absence of TEA, n : 6). The slopes of linear regressions of force vs halothane concentration did not differ between the two concentrations of ACh (922.4 (1.6) and 924.2 (1.2)% initial force % halothane 91 , respectively, P : 0.09), demonstrating that the potentiation of halothane-induced relaxation by TEA was not an artefact of functional antagonism. In other words, changes in the response to halothane produced by TEA could not be explained by the different ACh concentrations used to precontract TEA-treated and control strips. ; P : 0.0008 by paired t test). When added to strips precontracted with ACh, YM934 produced a concentration-dependent relaxation ( fig. 6 (top) ). Halothane exposure significantly attenuated the maximal decrease in force produced by YM934 (from 1001 (3.0) to 83.6 (5.5)% of the initial force; P : 0.05 by non-linear regression), without significantly changing the ED50 of YM934 (0.19 (0.03) and 0.30 (0.09) mol litre 91 for strips exposed and not exposed to halothane, respectively. The addition of the vehicle used to dissolve YM934 did not significantly affect force (data not shown). , respectively). The changes in the maximal decrease in force and ED50 produced by halothane and by increases in precontraction ACh concentration did not differ significantly. Thus it appears that the difference in YM934-induced relaxation observed in figure 6 can be accounted for by differences in ACh concentrations used to produce approximately equal initial forces.
Results
EFFECTS OF HALOTHANE AND K
Discussion
The principal findings of this study were that there was no interaction between halothane and a blocker of the KATP channel in their effects on force in isolated canine airway smooth muscle during stimulation with ACh, and that halothane had little effect on the ability of a KATP channel opener to relax airway smooth muscle. These findings do not support the hypothesis that halothane relaxes this tissue by opening KATP channels.
Potassium channels are important regulators of resting membrane potential in smooth muscle. In general, these channels are inhibited during agonistinduced contractions [21] , producing membrane depolarization which may contribute to extracellular calcium influx via voltage-dependent calcium channels. Conversely, compounds that open these channels tend to relax smooth muscle. It appears that ␤ adrenoreceptor agonists relax smooth muscle in part by augmenting potassium channel activity [22, 23] , and compounds that act primarily as potassium channel openers are currently being developed for therapeutic applications. At least three classes of potassium channels are present in airway smooth muscle [21] . Large-conductance, calciumactivated (KCa) channels are abundant in airway smooth muscle cell membranes and are modulated by agents that affect smooth muscle tone. Delayed rectifier potassium channels are open under resting conditions and may serve to stabilize membrane potential [24] . Although the ATP-sensitive potassium (KATP) channel has not been characterized fully in airway smooth muscle, there is considerable pharmacological evidence for its presence. The KATP channel openers cromakalim and levcromakalim hyperpolarize and relax airway smooth muscle [25, 26] , effects that can be antagonized by glibenclamide, a blocker of the KATP channel [27, 28] .
We found pharmacological evidence for the presence of both KCa and KATP channels in our prep- aration. Based on the lack of interaction between TEA and a KATP channel opener in our preparation ( fig. 4 ) and previous work finding little evidence of the effect of TEA (at 1 mmol litre 91 ) on delayed rectifier channels in airway smooth muscle [20] , we assume that TEA acted predominantly on the KCa channel, although effects on other channel types not yet identified in airway smooth muscle are possible. Block of KCa channels by TEA increased the sensitivity of the muscle to ACh-induced contraction, consistent with previous studies of smooth muscle [29] . Presumably, KCa channel block allowed a greater degree of membrane depolarization during block, leading to an increase in calcium influx, intracellular calcium concentration and force. Block of KATP channels by glibenclamide did not affect ACh-induced contractions, suggesting that this channel is not functionally important during this mode of stimulation in this tissue. However, during precontraction with ACh, this preparation was relaxed readily by the KATP channel opener YM934, a relaxation that was blocked by glibenclamide, indicating that KATP channels can modulate functional effects in this tissue.
Previous work has suggested that halothane and other anaesthetics modulate the function of several types of ion channels, including potassium channels. Inhibitory effects of halothane on KCa-channel function have been demonstrated in several different cell types, including vascular smooth muscle [13] , with an ED50 of approximately 0.5 mmol litre 91 in all studies. Halothane depresses 4-aminopyridinesensitive potassium currents in coronary arterial smooth muscle cells, suggesting antagonism of delayed rectifier potassium channels [7] . Halothane also depresses the function of a wide variety of both invertebrate and mammalian potassium channels with diverse functional characteristics [15] . In contrast, Franks and Lieb [10] have described a K ; channel in mollusc neurones that is activated by halothane.
Electrophysiological measurements of the effects of halothane specifically on the KATP channel have not yet been performed. However, some pharmacological studies have suggested that halothane may activate this channel. Larach and Schuler [12] found that glibenclamide inhibited halothane-induced vasodilatation of coronary resistance vessels in perfused rat hearts. However, this effect was not observed in isolated rings of epicardial coronary vessels denuded of endothelium; glibenclamide actually potentiated the effects of halothane in rings with intact endothelium. Mehr and Lindeman [11] measured the response of peripheral airway resistance, using a wedged bronchoscope technique, to hypocapnia produced by increasing flows of gas free of carbon dioxide in a canine model of asthma (the Basenji-Greyhound dog). They found that the response to hypocapnia was suppressed in dogs anaesthetized with 1.2 % halothane, compared with dogs anaesthetized with thiopentone and fentanyl. Pretreatment with glibenclamide aerosolized into the airway via the bronchoscope restored responsiveness to hypocapnia in dogs anaesthetized with halothane, and had no effect in dogs anaesthetized with thiopentone and fentanyl. They concluded that halothane suppressed the response of peripheral airways to hypocapnia by opening KATP channels.
In contrast with these findings, we found no interaction between the effects of halothane and glibenclamide in canine tracheal smooth muscle. The apparent antagonism by halothane of the ability of YM934, a potassium channel opener, to relax strips precontracted with ACh would suggest that halothane blocks KATP channels under these conditions. However, it appears that the results of this experiment may be explained primarily by functional antagonism; the effects of YM934 observed in halothane-treated muscles ( fig. 6 ) can be ascribed to the higher ACh concentration necessary to produce an initial force similar to that in control muscles (compare fig. 6 (top and bottom) ). Furthermore, there was no evidence of an interaction between the effects of halothane and YM934 on the ACh concentration-response relationship. Direct comparison of our results with the study of Mehr and Lindeman is not possible, because of differences in the breed of dog, location of the airway smooth muscle studied, method used to produce muscle contraction and differences in experimental condition (in vivo vs in vitro).
We also studied the interaction of halothane and TEA to determine if any effects of halothane that might have been observed in the glibenclamide procedures were specific to effects on the KATP channel. Halothane potentiated the effects of TEA on the ACh concentration-response relationship, and TEA potentiated the effect of halothane on muscles precontracted with ACh. Marijic and colleagues [29] observed a similar potentiation of halothane effect by TEA in vascular smooth muscle. The authors suggested, and provided supportive evidence in a subsequent study [7] , that halothane antagonized ion fluxes through both potassium and calcium channels. Antagonism of potassium channel function would favour membrane depolarization and increases in muscle tone; antagonism of calcium channel function would decrease intracellular calcium concentration and favour decreases in muscle tone. Under most circumstances, effects on calcium channels predominate, and the muscle relaxes when exposed to halothane. When potassium channels are blocked by TEA, halothane can inhibit only calcium channels, so that its relaxing effect is magnified. Our results are consistent with this explanation. Thus interference with the normal function of ion channels produced by anaesthetics may have opposite effects on physiological function, depending on the experimental conditions.
